Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expansion.

De Witte SFH, Peters FS, Merino A, Korevaar SS, Van Meurs JBJ, O'Flynn L, Elliman SJ, Newsome PN, Boer K, Baan CC, Hoogduijn MJ.

Cytotherapy. 2018 Jul;20(7):919-929. doi: 10.1016/j.jcyt.2018.05.005. Epub 2018 Jun 20.

PMID:
29934259
2.

Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells.

de Witte SFH, Luk F, Sierra Parraga JM, Gargesha M, Merino A, Korevaar SS, Shankar AS, O'Flynn L, Elliman SJ, Roy D, Betjes MGH, Newsome PN, Baan CC, Hoogduijn MJ.

Stem Cells. 2018 Apr;36(4):602-615. doi: 10.1002/stem.2779. Epub 2018 Feb 1.

3.

Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes.

Gonçalves FDC, Luk F, Korevaar SS, Bouzid R, Paz AH, López-Iglesias C, Baan CC, Merino A, Hoogduijn MJ.

Sci Rep. 2017 Sep 21;7(1):12100. doi: 10.1038/s41598-017-12121-z.

4.

Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function.

Luk F, Carreras-Planella L, Korevaar SS, de Witte SFH, Borràs FE, Betjes MGH, Baan CC, Hoogduijn MJ, Franquesa M.

Front Immunol. 2017 Aug 28;8:1042. doi: 10.3389/fimmu.2017.01042. eCollection 2017.

5.

Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile.

Wu Y, Hoogduijn MJ, Baan CC, Korevaar SS, de Kuiper R, Yan L, Wang L, van Besouw NM.

Stem Cells Int. 2017;2017:4960831. doi: 10.1155/2017/4960831. Epub 2017 May 31.

6.

Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.

de Witte SFH, Merino AM, Franquesa M, Strini T, van Zoggel JAA, Korevaar SS, Luk F, Gargesha M, O'Flynn L, Roy D, Elliman SJ, Newsome PN, Baan CC, Hoogduijn MJ.

Stem Cell Res Ther. 2017 Jun 8;8(1):140. doi: 10.1186/s13287-017-0590-6.

7.

Inactivated Mesenchymal Stem Cells Maintain Immunomodulatory Capacity.

Luk F, de Witte SF, Korevaar SS, Roemeling-van Rhijn M, Franquesa M, Strini T, van den Engel S, Gargesha M, Roy D, Dor FJ, Horwitz EM, de Bruin RW, Betjes MG, Baan CC, Hoogduijn MJ.

Stem Cells Dev. 2016 Sep 15;25(18):1342-54. doi: 10.1089/scd.2016.0068. Epub 2016 Aug 9.

PMID:
27349989
8.

Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection.

Saat TC, van den Engel S, Bijman-Lachger W, Korevaar SS, Hoogduijn MJ, IJzermans JN, de Bruin RW.

Stem Cells Int. 2016;2016:5761487. doi: 10.1155/2016/5761487. Epub 2016 Feb 11.

9.

Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression.

Hoogduijn MJ, de Witte SF, Luk F, van den Hout-van Vroonhoven MC, Ignatowicz L, Catar R, Strini T, Korevaar SS, van IJcken WF, Betjes MG, Franquesa M, Moll G, Baan CC.

Stem Cells Dev. 2016 Apr 15;25(8):586-97. doi: 10.1089/scd.2015.0329. Epub 2016 Mar 30.

PMID:
26914168
10.

Human renal tubular epithelial cells suppress alloreactive T cell proliferation.

Demmers MW, Korevaar SS, Roemeling-van Rhijn M, van den Bosch TP, Hoogduijn MJ, Betjes MG, Weimar W, Baan CC, Rowshani AT.

Clin Exp Immunol. 2015 Mar;179(3):509-19. doi: 10.1111/cei.12469.

11.

No evidence for circulating mesenchymal stem cells in patients with organ injury.

Hoogduijn MJ, Verstegen MM, Engela AU, Korevaar SS, Roemeling-van Rhijn M, Merino A, Franquesa M, de Jonge J, Ijzermans JN, Weimar W, Betjes MG, Baan CC, van der Laan LJ.

Stem Cells Dev. 2014 Oct 1;23(19):2328-35. doi: 10.1089/scd.2014.0269. Epub 2014 Aug 25.

PMID:
25105211
12.

Human Allogeneic Bone Marrow and Adipose Tissue Derived Mesenchymal Stromal Cells Induce CD8+ Cytotoxic T Cell Reactivity.

Roemeling-van Rhijn M, Reinders ME, Franquesa M, Engela AU, Korevaar SS, Roelofs H, Genever PG, Ijzermans JN, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ.

J Stem Cell Res Ther. 2013 Dec 12;3(Suppl 6):004.

13.

Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells.

Demmers MW, Korevaar SS, Betjes MG, Weimar W, Rowshani AT, Baan CC.

Transplantation. 2014 Jun 15;97(11):1110-8. doi: 10.1097/TP.0000000000000108.

PMID:
24704664
14.

Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model.

Roemeling-van Rhijn M, Khairoun M, Korevaar SS, Lievers E, Leuning DG, Ijzermans JN, Betjes MG, Genever PG, van Kooten C, de Fijter HJ, Rabelink TJ, Baan CC, Weimar W, Roelofs H, Hoogduijn MJ, Reinders ME.

J Stem Cell Res Ther. 2013 Nov 25;Suppl 6(1):20780.

15.

Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells.

Roemeling-van Rhijn M, Mensah FK, Korevaar SS, Leijs MJ, van Osch GJ, Ijzermans JN, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ.

Front Immunol. 2013 Jul 18;4:203. doi: 10.3389/fimmu.2013.00203. eCollection 2013.

16.

Mesenchymal stem cells induce an inflammatory response after intravenous infusion.

Hoogduijn MJ, Roemeling-van Rhijn M, Engela AU, Korevaar SS, Mensah FK, Franquesa M, de Bruin RW, Betjes MG, Weimar W, Baan CC.

Stem Cells Dev. 2013 Nov 1;22(21):2825-35. doi: 10.1089/scd.2013.0193. Epub 2013 Aug 9.

PMID:
23767885
17.

The effect of rabbit antithymocyte globulin on human mesenchymal stem cells.

Franquesa M, Baan CC, Korevaar SS, Engela AU, Roemeling-van Rhijn M, Weimar W, Betjes MG, Grinyo JM, Hoogduijn MJ.

Transpl Int. 2013 Jun;26(6):651-8. doi: 10.1111/tri.12109.

18.

Mesenchymal stem cells derived from adipose tissue are not affected by renal disease.

Roemeling-van Rhijn M, Reinders ME, de Klein A, Douben H, Korevaar SS, Mensah FK, Dor FJ, IJzermans JN, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ.

Kidney Int. 2012 Oct;82(7):748-58. doi: 10.1038/ki.2012.187. Epub 2012 Jun 13.

19.

Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.

Hoogduijn MJ, Roemeling-van Rhijn M, Korevaar SS, Engela AU, Weimar W, Baan CC.

Hum Gene Ther. 2011 Dec;22(12):1587-91. doi: 10.1089/hum.2011.039. Epub 2011 Aug 10.

PMID:
21732766
20.

Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells.

Crop MJ, Korevaar SS, de Kuiper R, IJzermans JN, van Besouw NM, Baan CC, Weimar W, Hoogduijn MJ.

Cell Transplant. 2011;20(10):1547-59. doi: 10.3727/096368910X564076. Epub 2011 Mar 7.

PMID:
21396164

Supplemental Content

Loading ...
Support Center